Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 104 (11) , 3861-3869
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulationsInternational Journal of Pharmaceutics, 2010
- Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditionsEuropean Journal of Pharmaceutical Sciences, 2010
- Lactose Composite Carriers for Respiratory DeliveryPharmaceutical Research, 2008
- The Influence of Mechanical Processing of Dry Powder Inhaler Carriers on Drug Aerosolization PerformanceJournal of Pharmaceutical Sciences, 2007
- Particle Engineering for Pulmonary Drug DeliveryPharmaceutical Research, 2007
- Dry powder inhalers for pulmonary drug deliveryExpert Opinion on Drug Delivery, 2004
- Pulmonary deposition of lactose carriers used in inhalation powdersInternational Journal of Pharmaceutics, 2000
- Enhancement of Small Particle Size Dry Powder Aerosol Formulations using an Ultra Low Density AdditivePharmaceutical Research, 1999
- Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulationInternational Journal of Pharmaceutics, 1999
- The Relationship Between Powder Inhaler Resistance and Peak Inspiratory Conditions in Healthy Volunteers — Implications for In Vitro TestingJournal of Aerosol Medicine, 1993